Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totaling 148,773 shares, an increase of 236.4% from the March 15th total of 44,231 shares. Based on an average daily volume of 175,045 shares, the short-interest ratio is presently 0.8 days. Currently, 163.5% of the shares of the company are sold short.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.
Read Our Latest Stock Analysis on Aditxt
Aditxt Price Performance
Aditxt (NASDAQ:ADTX – Get Free Report) last announced its quarterly earnings data on Tuesday, March 31st. The company reported $11,687.53 earnings per share (EPS) for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 1,217,927.00%.
Aditxt Company Profile
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
Read More
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
